Pi phenotypes of antiprotease α1 -antitrypsin and log dose slope of histamine responsiveness Source: Eur Respir J 2001; 18: Suppl. 33, 507s Year: 2001
Area under the reactance curve: Reference ranges and bronchodilator response (BDR) in healthy children Source: Annual Congress 2011 - Important new developments in paediatric respiratory physiology Year: 2011
Bronchial responsiveness measured as log dose slope (LDS) and maximum expiratory flow (MEF) and sensitation to storage mites Source: Eur Respir J 2002; 20: Suppl. 38, 120s Year: 2002
Will a cumulative dose reversibility test increase the power in a dose-response study comparing formoterol and terbutaline? Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001
Airway responsiveness to hypertonic saline: dose-response slope or PD15? Source: Eur Respir J 2005; 25: 153-158 Year: 2005
Change in phase 3 slope of exhaled CO2 in response to ß2 agonist inhalation is associated with asthma control in children Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017
A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003
Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Validation of a single concentration inhalation provocation test (SCIPT) in children Source: Eur Respir J 2002; 20: Suppl. 38, 540s Year: 2002
Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 473s Year: 2003
Acute asthma treatment: comparison of formoterol and salbutamol given in cumulative doses in children Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001
Relationship between bronchodilator response measured by FEV0.5 and methacholine provocation test in children from 3 to 15 years old Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
FEV1 and respiratory resistance response to methacholine in children calculated from between-measurement variability Source: Eur Respir J 2005; 26: Suppl. 49, 43s Year: 2005
Histamine challenges discriminate between symptomatic and asymptomatic children Source: Eur Respir J 2001; 17: 246-253 Year: 2001
Salmeterol increases histamine sensitivity in a model of sequential allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001
No-effect doses for effects on growth velocity (GV) in children receiving corticosteroids (CS) Source: Eur Respir J 2003; 22: Suppl. 45, 310s Year: 2003
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Use of within-breath Rrs values at 5 Hz to estimate resistive work of breathing during histamine challenge tests Source: Eur Respir J 2002; 20: Suppl. 38, 12s Year: 2002
The relationships of ΔFVC and PC20 on the dose-response curve to methacholine with peak expiratory flow variability in children with mild asthma Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014
Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response to low-dose ACTH test Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008